Valuation: Dr. Reddy's Laboratories Limited

Capitalization 1,05700Cr 1.1TCr 942.31Cr 864.22Cr 818.05Cr 1.52TCr 1.53TCr 10TCr 4.01TCr 50TCr 4.15TCr 4.06TCr 1,74300Cr P/E ratio 2026
24.4x
P/E ratio 2027 * 22.7x
Enterprise value 1,02900Cr 1.07TCr 916.67Cr 840.7Cr 795.79Cr 1.47TCr 1.49TCr 10TCr 3.9TCr 49TCr 4.03TCr 3.95TCr 1,69500Cr EV / Sales 2026
3.11x
EV / Sales 2027 * 2.8x
Free-Float
70.34%
Yield 2026 *
0.62%
Yield 2027 * 0.6%
1 day-0.75%
1 week-0.07%
Current month-3.99%
1 month+3.09%
3 months-0.35%
6 months+3.32%
Current year-0.07%
1 week 1,264.8
Extreme 1264.8
1,321.65
1 month 1,196.15
Extreme 1196.15
1,376
Current year 1,149
Extreme 1149
1,376
1 year 1,149
Extreme 1149
1,377.95
3 years 876.68
Extreme 876.68
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - -
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5d. change 1-year change 3-years change Capi.($)
-0.75%-0.07%+6.25%+42.21% 1.12TCr
+2.37%+0.10%+31.01%+127.85% 86TCr
+1.28%-0.57%+45.49%+39.48% 53TCr
+2.51%+0.85%+9.36%+41.26% 36TCr
-0.94%-1.00%+20.39%+10.73% 33TCr
+1.82%+3.14%+33.84%+14.47% 29TCr
+1.93%+2.08%+26.42%+25.26% 28TCr
+0.98%-0.69%+39.71%-4.07% 27TCr
-1.17%+3.71%-32.83%-49.56% 21TCr
+2.03%+2.03%+22.39%+44.36% 18TCr
Average +0.82%+0.91%+20.20%+29.20% 33.2TCr
Weighted average by Cap. +1.14%+0.57%+25.95%+47.48%

Financials

2026 2027 *
Net sales 34TCr 358.66Cr 305.9Cr 280.55Cr 265.57Cr 492.16Cr 496.86Cr 3.34TCr 1.3TCr 16TCr 1.35TCr 1.32TCr 57TCr 35TCr 367.14Cr 313.14Cr 287.19Cr 271.84Cr 503.79Cr 508.6Cr 3.42TCr 1.33TCr 17TCr 1.38TCr 1.35TCr 58TCr
Net income 5.08TCr 53Cr 45Cr 42Cr 39Cr 73Cr 74Cr 494.8Cr 192.68Cr 2.41TCr 199.29Cr 195.09Cr 8.38TCr 4.47TCr 47Cr 40Cr 36Cr 35Cr 64Cr 65Cr 434.64Cr 169.26Cr 2.12TCr 175.06Cr 171.37Cr 7.36TCr
Net Debt -2.88TCr -30Cr -26Cr -24Cr -22Cr -41Cr -42Cr -280.14Cr -109.09Cr -1.37TCr -112.83Cr -110.46Cr -4.74TCr -5.42TCr -57Cr -48Cr -44Cr -42Cr -78Cr -78Cr -527.78Cr -205.53Cr -2.57TCr -212.58Cr -208.09Cr -8.94TCr
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,811
Date Price Change Volume
13/26/13 1,278.40 +0.65% 1,48,762
12/26/12 1,270.10 -0.75% 1,15,843
11/26/11 1,279.70 -1.05% 47,674
08/26/08 1,293.25 -1.04% 35,545
07/26/07 1,306.80 -0.28% 38,933
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
38
Last Close Price
1,270.10INR
Average target price
1,328.95INR
Spread / Average Target
+4.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 500124 Stock